Bruker Corporation (BRKR)

Currency in USD
43.73
+1.43(+3.38%)
Closed·
44.00+0.27(+0.62%)
·
BRKR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
42.6244.28
52 wk Range
28.5356.22
Key Statistics
Prev. Close
42.3
Open
42.76
Day's Range
42.62-44.28
52 wk Range
28.53-56.22
Volume
2.8M
Average Volume (3m)
2.21M
1-Year Change
7.1639%
Book Value / Share
16.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BRKR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
47.71
Upside
+9.11%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Bruker Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

9 Buy
4 Hold
1 Sell
Ratings:
14 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 47.71
(+9.11% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Hold45.00+2.90%40.00MaintainMay 07, 2026
TD Cowen
Hold45.00+2.90%43.00MaintainMay 07, 2026
Barclays
Buy53.00+21.20%45.00MaintainMay 07, 2026
Jefferies
Buy53.00+21.20%50.00MaintainMay 06, 2026
Barclays
Buy45.00+2.90%50.00MaintainApr 15, 2026

Bruker Corporation Earnings Call Summary for Q1/2026

  • Bruker Q1 2026 EPS of $0.31 beat forecast of $0.23 by 34.78%; revenue reached $823.4M vs. $796.15M expected, stock rose 5.26% premarket.
  • Organic revenue declined 4.4% despite 2.7% overall growth; cost-saving initiatives provided 300 basis point benefit to operating margins.
  • Non-GAAP operating margin fell 250 bps to 10.2% YoY; free cash flow increased 20.5% to $47M despite EPS dropping from $0.47 to $0.31 YoY.
  • Management projects continued growth through innovation in NMR and spatial biology; analyst price targets range $35-$60 vs. current $38.01.
  • Key risks include persistent organic revenue decline, geopolitical pressures, supply chain disruptions, and FX headwinds in competitive markets.
Last Updated: 2026-05-06, 09:18 a/m
Read Full Transcript

Earnings

Latest Release
May 06, 2026
EPS / Forecast
0.31 / 0.23
Revenue / Forecast
823.4M / 796.15M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.15%
Dividend Yield
0.53%
Industry Median 1.56%
Annualized payout
0.20
Paid quarterly
5-Years Growth
+4.56%
Growth Streak

BRKR Income Statement

Compare BRKR to Peers and Sector

Metrics to compare
BRKR
Peers
Sector
Relationship
P/E Ratio
−182.9x21.4x−0.5x
PEG Ratio
2.39−1.390.00
Price/Book
2.7x2.1x2.6x
Price / LTM Sales
1.9x2.8x3.2x
Upside (Analyst Target)
17.0%50.1%48.3%
Fair Value Upside
Unlock0.5%5.6%Unlock

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
65.46M43.00%2.77B
Other Institutional Investors
74.49M48.93%3.15B
Public Companies & Retail Investors
12.27M8.06%519.21M
Total
152.22M100.00%6.44B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Orbis Investment Management Limited10.58%16,102,639681,142
BlackRock, Inc.7.21%10,967,706463,934

People Also Watch

22.66
SLM
+0.58%
27.40
RHI
+4.70%
295.42
AYI
-0.11%
43.31
OMCL
-1.03%

FAQ

What Is the Bruker (BRKR) Stock Price Today?

The Bruker stock price today is 43.73 USD.

What Stock Exchange Does Bruker Trade On?

Bruker is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Bruker?

The stock symbol for Bruker is "BRKR."

Does Bruker Pay Dividends? What’s The Current Dividend Yield?

The Bruker dividend yield is 0.47%.

What Is the Bruker Market Cap?

As of today, Bruker market cap is 6.66B USD.

What Is Bruker's Earnings Per Share (TTM)?

The Bruker EPS (TTM) is -0.15.

When Is the Next Bruker Earnings Date?

Bruker will release its next earnings report on Aug 05, 2026.

From a Technical Analysis Perspective, Is BRKR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Bruker Stock Split?

Bruker has split 0 times.

How Many Employees Does Bruker Have?

Bruker has 11085 employees.

What is the current trading status of Bruker (BRKR)?

As of May 07, 2026, Bruker (BRKR) is trading at a price of 43.73 USD, with a previous close of 42.30 USD. The stock has fluctuated within a day range of 42.62 USD to 44.28 USD, while its 52-week range spans from 28.53 USD to 56.22 USD.

What Is Bruker (BRKR) Price Target According to Analysts?

The average 12-month price target for Bruker is 47.71 USD, with a high estimate of 60 USD and a low estimate of 35 USD. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +9.11% Upside potential.

What Is the BRKR Premarket Price?

BRKR's last pre-market stock price is 42.97 USD. The pre-market share volume is 7,770.00, and the stock has decreased by 0.67, or 1.58%.

What Is the BRKR After Hours Price?

BRKR's last after hours stock price is 44.00 USD, the stock has decreased by 0.27, or 0.62%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.